ZNF746 and colorectal carcinoma: Inhibition of the ZNF746 signaling pathway, especially inhibition of the ZNF746 signaling target in combination therapy strategies, provides a key therapeutic strategy to reduce the resistance of CRC cells to chemotherapeutic agents.